Anteris Bio Overview
- Year Founded
-
2020
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Anteris Bio General Information
Description
Developer of a drug therapy company designed for the treatment of renal disease. The company focuses on the translational phase of drug development, enabling patients to get the availability of medicines by speeding up drugs in the market.
Contact Information
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
- 1111 Broadway
- Suite 1300
- Oakland, CA 94607
- United States
Corporate Office
- 1111 Broadway
- Suite 1300
- Oakland, CA 94607
- United States
Anteris Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 05-Nov-2024 | Completed | Out of Business | |||
| 1. Early Stage VC (Series A1) | 11-Dec-2020 | Completed | Startup |
Anteris Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A-2 |
Anteris Bio FAQs
-
When was Anteris Bio founded?
Anteris Bio was founded in 2020.
-
Where is Anteris Bio headquartered?
Anteris Bio is headquartered in Oakland, CA.
-
What industry is Anteris Bio in?
Anteris Bio’s primary industry is Drug Discovery.
-
Is Anteris Bio a private or public company?
Anteris Bio is a Private company.
-
What is Anteris Bio’s current revenue?
The current revenue for Anteris Bio is .
-
How much funding has Anteris Bio raised over time?
Anteris Bio has raised $2.5M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process